Clostridium Difficile Infection from a Surgical Perspective.
BACKGROUND
The incidence and the severity of Clostridium difficile infection (CDI) have increased significantly over the last decade, especially in high-risk populations such as patients with inflammatory bowel disease (IBD). Surgeons must be able to both identify and minimize the risk of CDI in their own surgical patients and determine which CDI patients will benefit from surgery.


OBJECTIVE
We sought to define the risk factors, compare the treatment options, define the surgical indications, and identify factors that affect surgical outcomes for CDI based on the currently available literature.


RESULTS
Antibiotic use, exposure to the C. difficile bacteria, IBD, and higher levels of co-morbidity are all risk factors for CDI. The majority of CDI can be treated with antibiotics. Severe or fulminant colitis, however, has a high potential for poor outcome, but experience and some data suggest a lower mortality rate with colectomy rather than with continued medical treatment. Open total abdominal colectomy with end ileostomy is typically the preferred surgical strategy. It is often difficult to determine which patients will fail medical management as some may not manifest clinical signs of severe infection. Surrogate parameters of failure of medical therapy include respiratory and/or renal insufficiency, age greater than 60 years, peripheral vascular disease, congestive heart failure, and coagulopathy, all of which have been associated with worse surgical outcomes. Evidence suggests that in appropriately selected patients, colectomy performed before the development of shock requiring vasopressors, respiratory failure, renal failure, multi-organ dysfunction, and mental status changes may reduce mortality of the most severe forms of colitis. For less severe or recurrent presentations, creation of a loop ileostomy with intra-operative colonic lavage, fecal microbiota transfer, and C. difficile vaccinations are being discussed but have only been studied in small case-controlled series.


CONCLUSIONS
Prevention, containment, and non-surgical treatment are the cornerstone of management for CDI. However, the most severe forms with toxic colitis benefit from involvement of a surgical team. Swift open total abdominal colectomy with end ileostomy in patients with severe or fulminant C. difficile colitis has the best chance to reduce mortality if it is not delayed until shock, end organ damage, vasopressor requirement, mental status changes develop. Less aggressive approaches may be appropriate for milder and refractory forms but require further study before their applicability can be determined.
Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Suite 7418, Los Angeles, 90033, CA, USA, akaiser@usc.edu.
Andreas M
AM
Kaiser
Rachel
R
Hogen
Liliana
L
Bordeianou
Karim
K
Alavi
Paul E
PE
Wise
Ranjan
R
Sudan
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000627:therapeutic use; D016360:Clostridioides difficile; D003082:Colectomy; D003092:Colitis / Q000188:drug therapy; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D000069467:Fecal Microbiota Transplantation; D006801:Humans; D007081:Ileostomy; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D017053:Infection Control / Q000379:methods; D015212:Inflammatory Bowel Diseases / Q000150:complications; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D016756:Immunoglobulins, Intravenous